EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115. A total of 5 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $20,000 | -62.3% | 133,097 | -12.0% | 0.00% | -66.7% |
Q4 2016 | $53,000 | 0.0% | 151,273 | -1.0% | 0.00% | +50.0% |
Q3 2016 | $53,000 | +960.0% | 152,773 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | -95.7% | 152,773 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $115,000 | -3.4% | 152,773 | -3.5% | 0.01% | -12.5% |
Q4 2015 | $119,000 | +395.8% | 158,273 | +467.8% | 0.01% | +700.0% |
Q3 2015 | $24,000 | – | 27,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 137,092 | $140,000 | 0.03% |
SABBY MANAGEMENT, LLC | 200,000 | $204,000 | 0.01% |
Vantage Investment Advisors, LLC | 2,500 | $3,000 | 0.00% |
Ionic Capital Management LLC | 27,873 | $24,000 | 0.00% |
BLACKROCK ADVISORS LLC | 5,906 | $6,000 | 0.00% |